PubMed=6946460; DOI=10.1073/pnas.78.8.5122; PMCID=PMC320345
Ueda R., Ogata S.-i., Morrissey D.M., Finstad C.L., Szkudlarek J., Whitmore W.F. Jr., Oettgen H.F., Lloyd K.O., Old L.J.
Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins.
Proc. Natl. Acad. Sci. U.S.A. 78:5122-5126(1981)

PubMed=6149219; DOI=10.1016/S0021-9258(18)90824-0
Andy R.J., Finstad C.L., Old L.J., Lloyd K.O., Kornfeld R.H.
The antigen identified by a mouse monoclonal antibody raised against human renal cancer cells is the adenosine deaminase binding protein.
J. Biol. Chem. 259:12844-12849(1984)

PubMed=3857626; DOI=10.1073/pnas.82.9.2955; PMCID=PMC397685
Finstad C.L., Cordon-Cardo C., Bander N.H., Whitmore W.F. Jr., Melamed M.R., Old L.J.
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer.
Proc. Natl. Acad. Sci. U.S.A. 82:2955-2959(1985)

Patent=US4713352
Bander N.H., Whitmore W.F. Jr., Old L.J.
Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma.
Patent number US4713352, 15-Dec-1987

Patent=US4935344
Bander N.H., Cordon-Cardo C., Finstad C.L., Whitmore W.F. Jr., Melamed M.R., Oettgen H.F., Old L.J.
Method for characterizing types of renal carcinoma and prognosis.
Patent number US4935344, 19-Jun-1990